Is renal Na+,K+-ATPase a new target for renin-angiotensin blocking agents in diabetic nephropathy?
Rossing
Peter
P
Steno Diabetes Center, Niels Steensens Vej 2, Gentofte, Denmark. pro@steno.dk
D000805:Angiotensin III; D000818:Animals; D003928:Diabetic Nephropathies / Q000188:drug therapy* / Q000201:enzymology*; D006801:Humans; D007668:Kidney / Q000187:drug effects / Q000201:enzymology*; D051381:Rats; D012084:Renin-Angiotensin System / Q000187:drug effects; D000254:Sodium-Potassium-Exchanging ATPase / Q000378:metabolism*
D000805:Angiotensin III; D000254:Sodium-Potassium-Exchanging ATPase